comparemela.com

Page 29 - Swedbank Robur News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Digital healthcare giant Babylon enters into $4 2bn SPAC deal

Digital healthcare giant Babylon enters into $4 2bn SPAC deal
cityam.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cityam.com Daily Mail and Mail on Sunday newspapers.

Swedbank toob Eesti turule kaks Põhjamaades populaarset võlakirjafondi

Swedbank toob Eesti turule kaks Põhjamaades populaarset võlakirjafondi
arileht.delfi.ee - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from arileht.delfi.ee Daily Mail and Mail on Sunday newspapers.

AAA-rated equity manager joins ex-Odin CIO s new boutique

AAA-rated equity manager joins ex-Odin CIO s new boutique
citywireselector.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from citywireselector.com Daily Mail and Mail on Sunday newspapers.

Isofol s Board of Directors resolves on a fully guaranteed preferential rights issue of approximately SEK 400 million

Isofol s Board of Directors resolves on a fully guaranteed preferential rights issue of approximately SEK 400 million News provided by Share this article GOTHENBURG, Sweden, May 18, 2021 /PRNewswire/   Isofol Medical AB s (publ), (Nasdaq First North Premier Growth Market: ISOFOL), ( Isofol or the Company ) Board of Directors has today, pursuant to the authorization granted by the extraordinary general meeting held on May 14, 2021 ( the EGM ), resolved on an issue of shares of a maximum of 62,524,474 shares with preferential rights for the Company s existing shareholders (the Rights Issue ). The subscription price in the Rights Issue is SEK 6.40 per share. If the Rights Issue is fully subscribed, the Company will receive approximately SEK 400 million before transaction costs related to the Rights Issue. In addition to the Rights Issue, and provided the Rights issue is oversubscribed, the Board of Directors is authorized to carry out a directed share issue with deviation from t

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.